34
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Independent prognostic value of MRI beyond existing methods of determining cardiovascular risk – is there a role?

, &

References

  • Go AS, Mozaffarian D, Roger VL et al. Executive summary: heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 127, 143–152 (2013).
  • Perk J, De Backer G, Gohlke H et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 33, 1635–1701 (2012).
  • Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 127, e6–e245 (2013).
  • Hundley WG, Bluemke DA et al.; American College of Cardiology Foundation Task Force on Expert Consensus D. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 121, 2462–2508 (2010).
  • Morrow DA, Antman EM, Charlesworth A et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102, 2031–2037 (2000).
  • Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92, 334–341 (1995).
  • Simonetti OP, Kim RJ, Fieno DS et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218, 215–223 (2001).
  • Wagner A, Mahrholdt H, Holly TA et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361, 374–379 (2003).
  • Ibrahim T, Bulow HP, Hackl T et al. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J. Am. Coll. Cardiol. 49, 208–216 (2007).
  • Hadamitzky M, Langhans B, Hausleiter J et al. Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison to single-photon emission tomography using Tc99m-sestamibi. Eur. Heart J. Cardiovasc. Imaging doi:10.1093/ehjci/jet176 (2013) ( Epub ahead of print).
  • de Waha S, Desch S, Eitel I et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur. Heart J. 31, 2660–2668 (2010).
  • Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97, 765–772 (1998).
  • Bax JJ, Poldermans D, Elhendy A et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J. Am. Coll. Cardiol. 34, 163–169 (1999).
  • Schwitter J, Wacker CM, van Rossum AC et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur. Heart J. 29, 480–489 (2008).
  • Klem I, Heitner JF, Shah DJ et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J. Am. Coll. Cardiol. 47, 1630–1638 (2006).
  • Cury RC, Cattani CA, Gabure LA et al. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology 240, 39–45 (2006).
  • Weir RA, Murphy CA, Petrie CJ et al. Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ. Cardiovasc. Imaging 3, 360–367 (2010).
  • Hachamovitch R, Berman DS, Shaw LJ et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97, 535–543 (1998).
  • Jahnke C, Nagel E, Gebker R et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115, 1769–1776 (2007).
  • Buckert D, Dewes P, Walcher T, Rottbauer W, Bernhardt P. Intermediate-term prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: a prospective follow-up study in a consecutive patient population. JACC Cardiovasc. Imaging 6, 56–63 (2013).
  • Gargiulo P, Dellegrottaglie S, Bruzzese D et al. The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis. Circ. Cardiovasc. Imaging 6, 574–582 (2013).
  • Kwong RY, Chan AK, Brown KA et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113, 2733–2743 (2006).
  • Kwong RY, Sattar H, Wu H et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 118, 1011–1020 (2008).
  • Bamberg F, Parhofer KG, Lochner E et al. Diabetes mellitus: long-term prognostic value of whole-body MR imaging for the occurrence of cardiac and cerebrovascular events. Radiology doi:10.1148/radiol.13130371 (2013) ( Epub ahead of print).
  • Xu J, Kim D, Otazo R et al. Towards a five-minute comprehensive cardiac MR examination using highly accelerated parallel imaging with a 32-element coil array: feasibility and initial comparative evaluation. J. Magn. Reson. Imaging 38, 180–188 (2013).
  • O’Meara E, Mielniczuk LM, Wells GA et al. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials 14, 218 (2013).
  • Petersen SE, Matthews PM, Bamberg F et al. Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank – rationale, challenges and approaches. J.Cardiovasc. Magn. Reson. 15, 46 (2013).
  • Miller CD, Hwang W, Case D et al. Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care. JACC Cardiovasc. Imaging 4, 862–870 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.